Fazila Seker, PhD, has 20 years of experience nurturing new technologies through the commercialization process in Canada and the U.S. by building teams, raising growth funds, and bringing people together for impact in healthcare, energy, and specialty materials sectors. She has held leadership roles with the GE Global Research Center in Niskayuna, NY; MaRS Innovation and, most recently, as Co-Founder, President and CEO of MOLLI Surgical in Toronto, Canada (acquired by Stryker).

Across her career, Fazila has developed a diverse portfolio of medical device opportunities with applications ranging from ultrasound to breast cancer. She also co-produced a crowd-funding campaign to promote a new medical device for monitoring breast cancer treatment. That work won national recognition in the Globe and Mail’s Top 10 Canadian crowdfunding list.

Under Fazila’s leadership, MOLLI Surgical established sales and clinical operations in the U.S. and Canada. Within four years, their efforts meant patients at some of the world’s top hospitals—such as Princess Margaret Cancer Centre in Toronto, Canada and The Christ Hospital Health Network in Ohio—were able to benefit from the company’s groundbreaking medical technology.

Building high-performance, award-winning cultures means Fazila’s teams have been recognized for their work across her career. Those accolades include Gold in the prestigious Medical Design Excellence Awards in the ER & OR (tools and supplies category); TIME Best Inventions 2022; Fast Company Next Big Things in Tech 2022; the 2021 list of Best WorkplacesTM Managed by Women; and the 2022 list of Best WorkplacesTM in Health Care.

• 

  Chief Executive Officer (CEO) in Insight Medbotics

  Robotics For More Targeted Care, Everywhere